Goldman Sachs’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,850,551
Closed -$538K 6020
2024
Q1
$538K Sell
2,850,551
-1,076,339
-27% -$244K ﹤0.01% 4718
2023
Q4
$638K Buy
3,926,890
+3,895,774
+12,520% +$1.29M ﹤0.01% 4622
2023
Q3
$13.8K Sell
31,116
-416,767
-93% -$190K ﹤0.01% 5384
2023
Q2
$165K Buy
447,883
+343,766
+330% +$293K ﹤0.01% 5239
2023
Q1
$189K Sell
104,117
-600,659
-85% -$1.31M ﹤0.01% 5317
2022
Q4
$1.46M Sell
704,776
-192,267
-21% -$607K ﹤0.01% 4164
2022
Q3
$2.7M Buy
897,043
+32,948
+4% +$117K ﹤0.01% 3709
2022
Q2
$2.77M Buy
864,095
+7,662
+0.9% +$41.5K ﹤0.01% 3755
2022
Q1
$5.52M Buy
856,433
+27,356
+3% +$247K ﹤0.01% 3256
2021
Q4
$11.1M Sell
829,077
-280,755
-25% -$3.09M ﹤0.01% 2665
2021
Q3
$13.1M Buy
+1,109,832
New +$17.5M ﹤0.01% 2452

Other funds holding HLTH

Goldman Sachs's HLTH Position: Q2 2024 in Review

Goldman Sachs sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 2,850,551 shares — an estimated $538K sold.

Goldman Sachs first reported a position in HLTH in Q3 2021 and held it in 11 quarters. The position peaked at $13.1M in Q3 2021. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Goldman Sachs reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Goldman Sachs sold 2,850,551 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $538K.
  • Goldman Sachs first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Goldman Sachs's Cue Health Inc. Common Stock position peaked at $13.1M in Q3 2021.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Goldman Sachs's 13F filing for Q2 2024, filed 13 Aug 2024.